Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Neuroscience
Alzheimer's Disease
100%
Lamivudine
51%
Frontotemporal Dementia
49%
Biological Marker
48%
Tauopathy
42%
Retroposon
41%
Genetics
30%
Neurotrauma
28%
Meta-Analysis
28%
Hippocampal Sclerosis
28%
Gray Matter Volume
28%
Memory Test
28%
Neuropsychiatric Symptom
28%
Frontal Variant Frontotemporal Dementia
28%
Traumatic Brain Injury
28%
Amyloid Protein
23%
Neurodegeneration
22%
Neurodegenerative Disorder
20%
Risk Factor
19%
Positron Emission Tomography
17%
Neuronal Cell Death
14%
Psychopathology
14%
Blood Plasma
14%
Plaque
11%
Glial Fibrillary Acidic Protein
9%
Nucleoside Analog
9%
Placebo
9%
Reverse-Transcriptase Inhibitor
9%
Gerontology
9%
Verbal Memory
9%
Intracranial Tumor
9%
Cerebrovascular Disease
9%
Amnesia
9%
Memory Disorder
9%
Cognitive Decline
9%
Parkinson's Disease
9%
Vascular Dementia
9%
Mild Cognitive Impairment
8%
Protein Aggregate
7%
Thalamus
7%
Tau Protein
7%
Psychosis
5%
Brain Network
5%
Dementia with Lewy Bodies
5%
Cognitive Function
5%
Cognitive Disorders
5%
Cerebral Amyloid Angiopathy
5%
Open-Label Trial
5%
Neurotoxicity
5%
Cerebrovascular Accident
5%
Medicine and Dentistry
Frontotemporal Lobar Degeneration
48%
Alzheimer's Disease
33%
Biological Marker
28%
Hippocampal Sclerosis
28%
Posterior Cortical Atrophy
28%
Meta-Analysis
28%
Cohort Analysis
28%
Body Mass Index
28%
Executive Function
28%
Mini-Mental State Examination
28%
Gray Matter
28%
Genetics
25%
Cognition
24%
Diseases
22%
Education
20%
Cardiovascular Risk
19%
Behavioral Risk Factor Surveillance System
19%
Hypercholesterolemia
19%
Diabetes
19%
Hypertension
19%
Allele
14%
Neurodevelopmental Disorder
14%
Cerebrospinal Fluid
10%
Polyethylene Terephthalate
10%
Conduct Disorder
9%
Lacunar Amnesia
9%
Verbal Memory
9%
Selection Bias
9%
Clinical Study
9%
Self Report
9%
Bland-Altman Plot
8%
Tau
7%
Amyloid Protein
7%
Healthy Aging
7%
Thalamus
7%
Degenerative Disease
7%
Clinical Symptom
7%
Group Dynamics
7%
Single Nucleotide Polymorphism
7%
Left Hemisphere
7%
Pharmacology, Toxicology and Pharmaceutical Science
Lamivudine
57%
Alzheimer's Disease
57%
Cognitive Defect
36%
Nervous System Inflammation
29%
Prostate Cancer
28%
Androgen
28%
Diseases
28%
Vortioxetine
28%
Drug Development
28%
Frontotemporal Dementia
28%
Rat
28%
Nerve Degeneration
23%
Biological Marker
22%
Tauopathy
15%
Degenerative Disease
14%
Amyloid Plaque
14%
Clinical Trial
12%
Placebo
11%
Glial Fibrillary Acidic Protein
11%
RNA Directed DNA Polymerase Inhibitor
11%
Nucleoside Analog
11%
Mild Cognitive Impairment
8%
Virus
7%
Neurotoxicity
7%
Open-Label Trial
7%
